181
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Experimental, Molecular Docking and Molecular Dynamics Investigation on Newly Synthesized Diethyl 4-(Anthracen-9-yl)-2,6-Dimethyl-1,4-Dihydropyridine-3,5-Dicarboxylate

, , &
Pages 5769-5784 | Received 24 Mar 2022, Accepted 19 Jul 2022, Published online: 08 Aug 2022

Reference

  • V.M. Briukhanov, I. Zverev, and V.I. Elkin, “The Effect of Calcium Antagonists on the Development of Inflammatory Edema in Rats,” Eksperimental'naia i Klinicheskaia Farmakologiia 57, no. 2 (1994): 47–9.
  • S. Bahekar, and D. Shinde, “Synthesis and anti-Inflammatory Activity of 1, 4-Dihydropyridines,” Acta Pharm 52 (2002): 281–7.
  • E. Praveenkumar, N. Gurrapu, P.K. Kolluri, V. Yerragunta, B.R. Kunduru, and N.J.P. Subhashini, “Synthesis, Anti-Diabetic Evaluation and Molecular Docking Studies of 4-(1-Aryl-1H-1, 2, 3-Triazol-4-yl)-1, 4-Dihydropyridine Derivatives as Novel 11-β Hydroxysteroid Dehydrogenase-1 (11β-HSD1) Inhibitors,” Bioorganic Chemistry 90 (2019): 103056.
  • Anil K. Chhillar, Pragya Arya, Chandrani Mukherjee, Pankaj Kumar, Yogesh Yadav, Ajendra K. Sharma, Vibha Yadav, Jyotsana Gupta, Rajesh Dabur, Hirday N. Jha, et al., “Microwave-Assisted Synthesis of Antimicrobial Dihydropyridines and Tetrahydropyrimidin-2-Ones: Novel Compounds against Aspergillosis,” Bioorganic & Medicinal Chemistry 14, no. 4 (2006): 973–81.
  • Y. Gao, B. Wang, S. Gao, R. Zhang, C. Yang, Z. Sun, and Z. Liu, “Design and Synthesis of 1, 4-Dihydropyridine and Cinnamic Acid Esters and Their Antioxidant Properties,” Chemical Research in Chinese Universities 32, no. 4 (2016): 594–9.
  • J.M. Tusell, S. Barro, and J. Serratosa, “Anticonvulsant Activity of δ-HCH, Calcium Channel Blockers and Calmodulin Antagonists in Seizures Induced by Lindane and Other Convulsant Drugs,” Brain Research 622, no. 1–2 (1993): 99–104.
  • José Marco-Contelles, Rafael León, Cristóbal de los Ríos, Abdelouahid Samadi, Manuela Bartolini, Vincenza Andrisano, Oscar Huertas, Xavier Barril, F. Javier Luque, María I. Rodríguez-Franco, et al., “Tacripyrines, the First Tacrine − Dihydropyridine Hybrids, as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease,” Journal of Medicinal Chemistry 52, no. 9 (2009): 2724–32.
  • P.O. Sjöquist, G. Adler, G. Duker, and O. Almgren, “Effects of Felodipine, a New Dihydropyridine Vasodilator, on Regional Myocardial Blood Flow during Acute Coronary Occlusion in the Pig,” Journal of Cardiovascular Pharmacology 5, no. 2 (1983): 202–6.
  • S. Gullapalli, and P. Ramarao, “L-Type Ca2+ Channel Modulation by Dihydropyridines Potentiates κ-Opioid Receptor Agonist Induced Acute Analgesia and Inhibits Development of Tolerance in Rats,” Neuropharmacology 42, no. 4 (2002): 467–75.
  • A. Waghmare, M. Kanyalkar, M. Joshi, and S. Srivastava, “In-Vitro Metabolic Inhibition and Antifertility Effect Facilitated by Membrane Alteration: Search for Novel Antifertility Agent Using Nifedipine Analogues,” European Journal of Medicinal Chemistry 46, no. 9 (2011): 3581–9.
  • G.A. Wächter, M.C. Davis, A.R. Martin, and S.G. Franzblau, “Antimycobacterial Activity of Substituted Isosteres of Pyridine-and Pyrazinecarboxylic Acids,” Journal of Medicinal Chemistry 41, no. 13 (1998): 2436–8.
  • A. Hilgeroth, and H. Lilie, “Structure-Activity Relationships of First Bishydroxymethyl-Substituted Cage Dimeric 4-Aryl-1, 4-Dihydropyridines as HIV-1 Protease Inhibitors,” European Journal of Medicinal Chemistry 38, no. 5 (2003): 495–9.
  • M. De Luca, G. Ioele, and G. Ragno, “1, 4-Dihydropyridine Antihypertensive Drugs: Recent Advances in Photostabilization Strategies,” Pharmaceutics 11, no. 2 (2019): 85.
  • M. Schramm, G. Thomas, R. Towart, and G. Franckowiak, “Novel Dihydropyridines with Positive Inotropic Action through Activation of Ca2+ Channels,” Nature 303, no. 5917 (1983): 535–7.
  • G. Rovnyak, N. Andersen, J. Gougoutas, A. Hedberg, S.D. Kimball, M. Malley, S. Moreland, M. Porubcan, and A. Pudzianowski, “Active Conformation of 1, 4-Dihydropyridine Calcium Entry Blockers. Effect of Size of 2-Aryl Substituent on Rotameric Equilibria and Receptor Binding,” Journal of Medicinal Chemistry 34, no. 8 (1991): 2521–4.
  • C. Bladen, M.G. Gündüz, R. Şimşek, C. Şafak, and G.W. Zamponi, “Synthesis and Evaluation of 1, 4-Dihydropyridine Derivatives with Calcium Channel Blocking Activity, Pflügers Arch,” Pflugers Archiv : European Journal of Physiology 466, no. 7 (2014): 1355–63.
  • B. Desai, D. Sureja, Y. Naliapara, A. Shah, and A.K. Saxena, “Synthesis and QSAR Studies of 4-Substituted Phenyl-2, 6-Dimethyl-3, 5-bis-N-(Substituted Phenyl) Carbamoyl-1, 4-Dihydropyridines as Potential Antitubercular Agents,” Bioorganic & Medicinal Chemistry 9, no. 8 (2001): 1993–8.
  • A. Hantzsch, “Ueber die synthese pyridinartiger verbindungen aus acetessigäther und aldehydammoniak,” Justus Liebig's Annalen Der Chemie 215, no. 1 (1882): 1–82.
  • M.J. Frisch, G.W. Trucks, H.B.Schlegel, G.E.Scuseria, M.A.Robb, J.R.Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G.A. Petersson, et al., Gaussian 09, Revision D.01, vol. 121 (Wallingford CT: Gaussian, Inc., 2009), 150–66.
  • M.H. Jamroz, “Vibrational Energy Distribution Analysis VEDA 4,” 2004. https://smmg.pl/software/veda
  • F. Weinhold, and C.R. Landis, “Natural Bond Orbitals and Extensions of Localized Bonding Concepts,” Chemical Education Research and Practice 2, no. 2 (2001): 91–104.
  • R.D. Dennington, T.A. Keith, and J.M. Millam, GaussView 5.0 (Wallingford CT: Gaussian, Inc., 2008).
  • G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, and A.J. Olson, “AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility,” Journal of Computational Chemistry 30, no. 16 (2009): 2785–91.
  • G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, and A.J. Olson, “Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function,” Journal of Computational Chemistry 19, no. 14 (1998): 1639–62.
  • K.J. Bowers, D.E. Chow, H. Xu, R.O. Dror, M.P. Eastwood, B.A. Gregersen, J.L. Klepeis, I. Kolossvary, M.A. Moraes, and F.D. Sacerdoti, “Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters” (SC’06 Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, IEEE, 2006), 43.
  • DE Shaw Research, Schrödinger Release, 3: Desmond Molecular Dynamics System (New York, NY: Maest. Interoperability Tools, Schrödinger, 2017).
  • R. Boulcina, S. Bouacida, T. Roisnel, and A. Debache, “Diethyl 4-(4-Bromophenyl)-2, 6-Dimethyl-1, 4-Dihydropyridine-3, 5-Dicarboxylate,” Acta Crystallographica Section E Structure Reports Online 63, no. 8 (2007): o3635–o3636.
  • V. Langer, and H.-D. Becker, “Crystal Structure of 10-Phenyl-9-Anthraldehyde, C21H14O, Zeitschrift Für Krist,” Mater 207 (1993): 156–8.
  • R.D. Johnson, “NIST Computational Chemistry Comparison and Benchmark Database,” 2006 http://srdata.nist.gov/cccbdb.
  • C. Sridevi, G. Shanthi, and G. Velraj, “Structural, Vibrational, Electronic, NMR and Reactivity Analyses of 2-Amino-4H-Chromene-3-Carbonitrile (ACC) by ab Initio HF and DFT Calculations,” Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 89 (2012): 46–54.
  • C. Alaşalvar, N. Öztürk, A.-M. Alaa, H. Gökce, A.S. El-Azab, M.A. El-Gendy, and Y. Sert, “Molecular Structure, Hirshfeld Surface Analysis, Spectroscopic (FT-IR, Laser-Raman, UV–Vis. and NMR), HOMO-LUMO and NBO Investigations on N-(12-Amino-9, 10-Dihydro-9, 10-Ethanoanthracen-11-yl)-4-Methylbenzenesulfonamide,” Journal of Molecular Structure 1171 (2018): 696–705.
  • A.A. Abdulridha, M.A.A.H. Allah, S.Q. Makki, Y. Sert, H.E. Salman, and A.A. Balakit, “Corrosion Inhibition of Carbon Steel in 1 M H2SO4 Using New Azo Schiff Compound: Electrochemical, Gravimetric, Adsorption, Surface and DFT Studies,” Journal of Molecular Liquids 315 (2020): 113690.
  • A. Lakshmi, V. Balachandran, and A. Janaki, “Comparative Vibrational Spectroscopic Studies, HOMO–LUMO and NBO Analysis of 5, 7-Dibromo-8-Hydroxyquinoline and 5, 7-Dichloro-8-Hydroxyquinoline Based on Density Functional Theory,” Journal of Molecular Structure 1004, no. 1–3 (2011): 51–66.
  • E. Scrocco, and J. Tomasi, “Electronic Molecular Structure, reactivity and intermolecular Forces: An Euristic Interpretation by Means of Electrostatic Molecular Potentials,” Advances in Quantum Chemistry 11 (1978): 115–93.
  • F.J. Luque, J.M. López, and M. Orozco, “Perspective on “Electrostatic Interactions of a Solute with a Continuum. A Direct Utilization of ab Initio Molecular Potentials for the Prevision of Solvent Effects,” Theoretical Chemistry Accounts 103, no. 3–4 (2000): 343–5.
  • Y.S. Mary, Y.S. Mary, S. Armaković, S.J. Armaković, M. Krátký, J. Vinsova, C. Baraldi, and M.C. Gamberini, “Concentration and Solvent Dependent SERS, DFT, MD Simulations and Molecular Docking Studies of a Thioxothiazolidine Derivative with Antimicrobial Properties,” Journal of Molecular Liquids 329 (2021): 115582.
  • E.D. Glendening, A.E. Reed, J.E. Carpenter, and F. Weinhold, NBO Version 3.1 (Pittsburgh, PA: Gaussian, Inc., 2003).
  • C. James, C. Ravikumar, T. Sundius, V. Krishnakumar, R. Kesavamoorthy, V.S. Jayakumar, and I.H. Joe, “FT-Raman and FTIR Spectra, Normal Coordinate Analysis and Ab Initio Computations of (2-Methylphenoxy) Acetic Acid Dimer,” Vibrational Spectroscopy 47, no. 1 (2008): 10–20.
  • T. Kavitha, and G. Velraj, “Density Functional Theory Analysis and Molecular Docking Evaluation of 1-(2, 5-Dichloro-4-Sulfophenyl)-3-Methyl-5-Pyrazolone as COX2 Inhibitor against Inflammatory Diseases,” Journal of Molecular Structure 1141 (2017): 335–45. https://doi.org/10.1016/j.molstruc.2017.03.061.
  • I. Fleming, Frontier Orbitals and Organic Chemical Reactions (London: Wiley, 1977).
  • P.K. Murthy, M. Smitha, Y.S. Mary, S. Armaković, S.J. Armaković, R.S. Rao, P.A. Suchetan, L. Giri, R. Pavithran, and C. Van Alsenoy, “Supramolecular Architecture of 5-Bromo-7-Methoxy-1-Methyl-1H-Benzoimidazole. 3H2O: Synthesis, Spectroscopic Investigations, DFT Computation, MD Simulations and Docking Studies,” Journal of Molecular Structure 1149 (2017): 602–12.
  • R.G. Parr, “Density Functional Theory of Atoms and Molecules,” in Horizons Quantum Chemistry, ed. K. Fukui and B. Pullman (Dordrecht: Springer, 1980), 5–15.
  • H. Gökce, F. Şen, Y. Sert, B.F. Abdel-Wahab, B.M. Kariuki, and G.A. El-Hiti, “Quantum Computational Investigation of (E)-1-(4-Methoxyphenyl)-5-methyl-N′-(3-Phenoxybenzylidene)-1 H-1, 2, 3-Triazole-4-Carbohydrazide,” Molecules 27, no. 7 (2022): 2193.
  • S. Kansız, A. Tolan, M. Azam, N. Dege, M. Alam, Y. Sert, S.I. Al-Resayes, and H. İçbudak, “Acesulfame Based Co (II) Complex: Synthesis, Structural Investigations, Solvatochromism, Hirshfeld Surface Analysis and Molecular Docking Studies,” Polyhedron 218 (2022): 115762.
  • W.L. Jorgensen, “The Many Roles of Computation in Drug Discovery,” Science 303, no. 5665 (2004): 1813–8.
  • L. Tang, T.M.G. El-Din, T.M. Swanson, D.C. Pryde, T. Scheuer, N. Zheng, and W.A. Catterall, “Structural Basis for Inhibition of a Voltage-Gated Ca2+ Channel by Ca2+ Antagonist Drugs,” Nature 537, no. 7618 (2016): 117–21.
  • J. Sebhaoui, Y.El. Bakri, C.-H. Lai, S. Karthikeyan, E.H. Anouar, J.T. Mague, and E.M. Essassi, “Unexpected Synthesis of Novel 2-Pyrone Derivatives: crystal Structures, Hirshfeld Surface Analysis and Computational Studies,” Journal of Biomolecular Structure and Dynamics 39, no. 13 (2020): 1–19.
  • Youness El Bakri, El Hassane Anouar, Karthikeyan Subramani, Ali Ben-Yahya, and El Mokhtar Essassi, “Synthesis, Spectroscopic Characterizations, DFT, Molecular Docking and Molecular Dynamics Simulations of a Novel 2-Methyl-3H-Benzimidazolo [1, 2-b][1, 2, 4] Triazepin-4 (5H)-One,” Journal of Molecular Structure 1202 (2020): 127317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.